Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BRZENASDAQ:DOCSNYSE:KVYONASDAQ:NICE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBRZEBraze$26.82-0.6%$32.10$26.26▼$48.33$2.83B1.221.29 million shs1.38 million shsDOCSDoximity$57.10-2.4%$55.44$25.00▼$85.21$10.72B1.322.15 million shs2.00 million shsKVYOKlaviyo$33.81-1.7%$32.05$21.26▼$49.55$10.05B1.441.55 million shs1.61 million shsNICENice$165.33-0.3%$162.16$137.19▼$200.65$10.46B1.01527,883 shs510,587 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBRZEBraze0.00%-5.83%-24.37%-27.57%-23.65%DOCSDoximity0.00%+0.24%+7.71%-9.38%+107.17%KVYOKlaviyo0.00%+0.40%-0.66%+2.46%+50.52%NICENice0.00%-3.56%-0.69%+5.45%-0.79%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBRZEBraze3.7843 of 5 stars4.53.00.00.02.43.30.6DOCSDoximity3.246 of 5 stars3.30.00.00.02.24.21.3KVYOKlaviyo4.4735 of 5 stars4.44.00.00.02.34.21.9NICENice4.1717 of 5 stars4.33.00.00.02.71.72.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBRZEBraze 2.95Moderate Buy$46.6073.75% UpsideDOCSDoximity 2.59Moderate Buy$62.8410.06% UpsideKVYOKlaviyo 2.80Moderate Buy$43.2127.82% UpsideNICENice 2.69Moderate Buy$208.9226.36% UpsideCurrent Analyst Ratings BreakdownLatest BRZE, NICE, DOCS, and KVYO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/18/2025NICENiceRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$200.006/18/2025NICENiceCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$161.006/18/2025NICENiceJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$300.006/18/2025NICENiceRosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$190.006/13/2025KVYOKlaviyoWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$32.00 ➝ $40.006/13/2025NICENicePiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$153.00 ➝ $182.006/6/2025BRZEBrazeOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$51.00 ➝ $44.006/6/2025BRZEBrazeRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$48.00 ➝ $43.006/6/2025BRZEBrazeLoop CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$75.00 ➝ $45.006/6/2025BRZEBrazeMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$40.00 ➝ $35.006/6/2025BRZEBrazeJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$47.00 ➝ $45.00(Data available from 6/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBRZEBraze$593.41M4.77N/AN/A$4.49 per share5.97DOCSDoximity$570.40M18.80$0.70 per share81.32$5.52 per share10.34KVYOKlaviyo$937.46M10.71$0.39 per share87.37$3.79 per share8.92NICENice$2.74B3.82$11.85 per share13.95$56.97 per share2.90Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBRZEBraze-$103.74M-$1.01N/AN/AN/A-16.76%-18.89%-10.26%9/4/2025 (Estimated)DOCSDoximity$147.58M$1.1157.1053.364.1036.60%21.75%18.64%N/AKVYOKlaviyo-$46.14M-$0.18N/A422.58N/A-4.70%0.74%0.61%8/6/2025 (Estimated)NICENice$442.59M$7.1723.0615.211.5016.77%16.37%11.15%8/21/2025 (Estimated)Latest BRZE, NICE, DOCS, and KVYO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/5/2025Q1 2026BRZEBraze$0.05$0.07+$0.02-$0.34$158.60 million$162.06 million5/15/2025N/ADOCSDoximity$0.27$0.38+$0.11N/AN/AN/A5/15/2025Q1 2025NICENice$2.84$2.87+$0.03$2.01$699.46 million$700.19 million5/6/2025Q1 2025KVYOKlaviyo$0.12$0.14+$0.02-$0.05$267.79 million$279.83 million3/27/2025Q4 2025BRZEBraze$0.05$0.12+$0.07-$0.17$155.72 million$160.40 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBRZEBrazeN/AN/AN/AN/AN/ADOCSDoximityN/AN/AN/AN/AN/AKVYOKlaviyoN/AN/AN/AN/AN/ANICENiceN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBRZEBrazeN/A1.921.92DOCSDoximityN/A8.748.74KVYOKlaviyoN/A5.225.22NICENiceN/A1.601.60Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBRZEBraze90.47%DOCSDoximity87.19%KVYOKlaviyo45.43%NICENice63.34%Insider OwnershipCompanyInsider OwnershipBRZEBraze18.20%DOCSDoximity37.40%KVYOKlaviyo49.92%NICENice0.02%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBRZEBraze1,699105.61 million86.39 millionOptionableDOCSDoximity890187.83 million116.87 millionNot OptionableKVYOKlaviyo2,182296.99 million148.73 millionOptionableNICENice8,72663.25 million63.24 millionOptionableBRZE, NICE, DOCS, and KVYO HeadlinesRecent News About These CompaniesNice's (NICE) Outperform Rating Reiterated at Royal Bank Of CanadaJune 20 at 1:46 AM | americanbankingnews.comSilly Nice Launches High-THC Full Spectrum Weed Drops Across New York Just in Time for SummerJune 19 at 6:47 PM | manilatimes.netNICE or VRRM: Which Is the Better Value Stock Right Now?June 19 at 12:41 PM | zacks.comWall Street Analysts See Nice (NICE) as a Buy: Should You Invest?June 19 at 10:36 AM | zacks.comBenefits of Alzheimer’s drugs remain too small to justify costs, says NICEJune 19 at 6:38 AM | bmj.comOGC Nice’s Marcin Bulka unenthused by Galatasaray moveJune 19 at 6:38 AM | sports.yahoo.comJMP Securities Reiterates Market Outperform Rating for Nice (NASDAQ:NICE)June 19 at 2:50 AM | americanbankingnews.comNice (NASDAQ:NICE) Earns Buy Rating from Rosenblatt SecuritiesJune 19 at 2:50 AM | americanbankingnews.comCan NiCE Hit the Jackpot With Agentic AI and New Brand Vision?June 19 at 1:37 AM | cmswire.comFrom Chatbots To Digital Workers: Why NiCE’s AI Focuses On ExecutionJune 19 at 1:37 AM | forbes.comAs Carney and Modi make nice, Sikh Canadians say they still face threatsJune 19 at 1:37 AM | msn.comRoyal Bank Of Canada Reiterates "Outperform" Rating for Nice (NASDAQ:NICE)June 18 at 12:35 PM | marketbeat.comNice's (NICE) Neutral Rating Reiterated at Cantor FitzgeraldJune 18 at 10:26 AM | marketbeat.comJMP Securities Reaffirms "Market Outperform" Rating for Nice (NASDAQ:NICE)June 18 at 8:40 AM | marketbeat.comRosenblatt Securities Reaffirms Buy Rating for Nice (NASDAQ:NICE)June 18 at 8:05 AM | marketbeat.comNiCE Announces Elite Partners of the Year Awards at Interactions 2025, Driving Worldwide Acceleration of CX AutomationJune 18 at 7:30 AM | businesswire.comBfsg LLC Purchases Shares of 10,298 Nice (NASDAQ:NICE)June 18 at 4:50 AM | marketbeat.comThe Often-Ignored Reason Women Don’t Choose The Nice Guy, According To ResearchJune 18 at 3:33 AM | yourtango.comMinnesota's 'nice' culture shattered by political violenceJune 18 at 3:33 AM | msn.comNice (NASDAQ:NICE) Given Average Rating of "Moderate Buy" by BrokeragesJune 18 at 1:50 AM | marketbeat.comNice (NICE) Upgraded to Buy: Here's WhyJune 17 at 1:00 PM | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBRZE, NICE, DOCS, and KVYO Company DescriptionsBraze NASDAQ:BRZE$26.82 -0.17 (-0.63%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$26.96 +0.13 (+0.50%) As of 06/18/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Braze, Inc. operates a customer engagement platform that provides interactions between consumers and brands worldwide. The company offers Braze software development kits that automatically manage data ingestion and deliver mobile and web notifications, in-application/in-browser interstitial messages, and content cards; REST API that can be used to import or export data or to trigger workflows between Braze and brands' existing technology stacks; Partner Data Integrations, which allow brands to sync user cohorts from partners; Data Transformation, in which brands can programmatically sync and transform user data; and Braze Cloud Data Ingestion that enables brands to harness their customer data. It also offers classification products, including segmentation that can define reusable segments of consumers based upon attributes, events, or predictive propensity scores; segment insights, which allows customers to analyze how segments are performing relative to each other across a set of pre-selected key performance indicators; and predictive suite that allows customers to identify groups of consumers that are of critical business value. In addition, the company provides Canvas, an orchestration tool that allows customers to create journeys, mapping out multi-steps, and cross-channel messaging experiences; campaigns, which allows customers to send one set of single-channel or multi-channel messages to be delivered to customers in a particular user segment; event and API triggering; marketing pressure management; and reporting and analytics. Further, it offers personalization products, such as liquid templating platform, connected content platform, content blocks, intelligent timing and channel, personalized variant, and AI item recommendations, and catalogs; and action products. The company was formerly known as Appboy, Inc. and changed its name to Braze, Inc. in November 2017. Braze, Inc. was incorporated in 2011 and is headquartered in New York, New York.Doximity NASDAQ:DOCS$57.10 -1.41 (-2.41%) Closing price 06/18/2025 03:59 PM EasternExtended Trading$57.04 -0.06 (-0.10%) As of 06/18/2025 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.Klaviyo NYSE:KVYO$33.81 -0.59 (-1.73%) Closing price 06/18/2025 03:59 PM EasternExtended Trading$33.63 -0.18 (-0.52%) As of 06/18/2025 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Klaviyo, Inc., a technology company, provides a software-as-a-service platform in the United States, other Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers Klaviyo, a cloud-native platform for data store, segmentation engine, campaigns and flows, and messaging infrastructure. It also provides email to send personalized marketing emails, including drag-and-drop email templates to edit and customize pre-built templates; email campaigns and automations with smart send time features, generative artificial intelligence for subject line creation, A/B testing tools, and consumer list segmentation; short message services to send targeted marketing text messages to consumers, as well as built-in contact cards to ensure that texts does not appear as random numbers; and push, a personalized push notification to engage with consumer. In addition, the company offers other applications, such as reviews, which collect product reviews; and customer data platform that allows to manage, deploy, transform, and sync data. It serves its products to entrepreneurs, small and medium-sized businesses to mid-market businesses, and enterprises. The was incorporated in 2012 and is headquartered in Boston, Massachusetts.Nice NASDAQ:NICE$165.33 -0.43 (-0.26%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$165.26 -0.08 (-0.05%) As of 06/18/2025 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NICE Ltd., together with its subsidiaries, provides cloud platforms for AI-driven digital business solutions worldwide. It offers CXone, a cloud native open platform; Enlighten, an AI engine for the customer engagement market; and smart self service enable organizations to address consumers' needs; and journey orchestration solutions that empower organizations to connect and route customers to deal with the customer's request, and connects them using real time AI-based routing. The company provides smart self service solutions that empower organizations to build intelligent automated conversations based on data; and prepared agent solutions and tools enable contact center agents to guide and alert them in real time; provides solutions that help organizations to record structured and unstructured customer interaction and transaction data; and NICE Evidencentral, an digital evidence management platform for public safety emergency communications, law enforcement, and criminal justice helps agencies. In addition, it offers X-Sight, is an open and flexible AI-cloud platform for financial crime and compliance; Xceed, a cloud platform for comprehensive AML and fraud prevention for small and mid-sized organizations; data intelligence solutions that enable organizations to turn raw data into comprehensive actionable intelligence to prevent and detect financial crimes; AI and analytics technologies to detect and prevent financial crimes in real-time; money laundering and fraud prevention solutions that help organizations adhere to capital markets compliance and anti-money laundering compliance regulations; intelligent investigations solutions; and self-service solutions that provide organizations with customization and self-development capabilities. The company was formerly known as NICE-Systems Ltd. and changed its name to NICE Ltd. in June 2016. NICE Ltd. was founded in 1986 and is headquartered in Ra'anana, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Chime’s Smart IPO: Half the Valuation, Double the Strength 3 Tech Stocks With High and Rising Institutional Interest Salesforce Raises Prices: 3 Reasons Its Stock Price Will Follow Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
